Valued at a market cap of $9.6 billion, Cambridge, Massachusetts-based Moderna, Inc. (MRNA) is a biotechnology company that focuses on developing messenger RNA (mRNA) medicines and vaccines.

Moderna stock hasn’t been a favorite of investors since demand for its coronavirus vaccine started to drop. But this biotech is showing the market that it has what it takes to produce multiple ...

The most recent trading session ended with Moderna (MRNA) standing at $24.73, reflecting a -1.85% shift from the previouse trading day's closing. The stock's performance was behind the S&P 500's ...

Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key regulatory hurdle at its flagship production plant in the United Kingdom.

If you’re on the fence about investing in Moderna, Inc. or Alvotech because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision. Read on to ...

US mRNA specialist Moderna (Nasdaq: MRNA) has announced that the German Standing Committee on Vaccination (STIKO) has issued a recommendation for mRESVIA, the company’s RSV vaccine available in a ...

If you’re on the fence about investing in Ultragenyx Pharmaceutical Inc., Moderna or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making ...

US stocks skyrocketed higher after President Donald Trump announced that he authorized a 90-day pause on the “reciprocal” tariffs that had gone into effect Wednesday, with the exception of ...

CAMBRIDGE, MA / ACCESS Newswire / April 7, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present research across multiple infectious disease areas, including COVID-19 ...

CAMBRIDGE, MA - Moderna Inc (BMV:MRNA). (NASDAQ:MRNA) is set to present a series of scientific studies at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global ...

CAMBRIDGE, MA / ACCESS Newswire / April 7, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present research across multiple infectious disease areas, including COVID-19, ...